Hints and tips:
...He also served as chief executive of Pharmacia Corporation and was also a partner at Warburg Pincus from 2011 to 2017....
...The academics needed an industrial partner, but Mr Curstedt says that Pharmacia, a Swedish drugs company which has since become part of Pfizer, felt “the sales were too small and the marketing costs too...
...The sale of Meda risks a further hollowing out of Sweden’s pharmaceuticals sector, which in the past two decades has seen Pharmacia bought by Pfizer of the US and Astra merged with Zeneca of the UK....
...The company admitted defeat in November after failing to win enough support from Perrigo’s shareholders....
...Sweden has fretted about the erosion of its life science industry since the partial loss of Astra and the sale of Pharmacia to Pfizer in 2002, but AstraZeneca still employs about 5,900 people in the country...
...Three years later it acquired Pharmacia for $60bn then, in 2009, Wyeth for $68bn. More recently came Hospira for another $17bn....
...to Upjohn of the US and then Pfizer....
...When Pfizer took the company over in 2003, it had long ceased to have its headquarters in Sweden, with it having moved to first the UK and then the US as part of a 1995 merger with Upjohn of the US....
...The company declined to comment on the Pharmacia deal....
...Mr Heldin said foreign takeovers of both Astra and Pharmacia, which was first bought in 1995 by Upjohn of the US, had been “very bad” for Sweden....
...He said the commitments offered by Pfizer “fly in the face of what they have done when they have acquired companies in the past”, pointing to job losses after takeovers of Pharmacia and Warner Lambert....
...Pharmacia co-authored about 200 Swedish research papers each year through the 1990s....
...Pfizer has a history of big acquisitions, such as its $68bn takeover of Wyeth in 2009 and its $56bn deal with Pharmacia in 2002....
...Mr Borg had earlier criticised Pfizer’s behaviour after taking over Swedish group Pharmacia a decade ago....
...“There is its acquisition of Warner-Lambert in 2000 in the US; Pharmacia in Sweden in 2003; and Wyeth in the US in 2000, and that led to deep cuts in the research facilities, it led to intellectual asset-stripping...
...Two years later, Hank McKinnell, Mr Steere’s replacement, launched a $60bn takeover of Pharmacia, securing drugs including Celebrex, then part of a promising class of new painkillers....
...Since 2000, the company has spent more than $200bn on the acquisition of Warner-Lambert, Pharmacia and Wyeth. Yet, the deals have done little to improve the underlying trend....
...So has the independence of that country’s entire pharmaceutical sector, with Pharmacia absorbed by Pfizer of the US and Astra merged into AstraZeneca, based in the UK....
...of 42 medicines approved by CDSCO officials and examined by the health committee, it said 11 had not involved mandatory late stage trials in patients, including drugs made by GlaxoSmithKline, Sanofi and Pharmacia...
...Pfizer has led the consolidation, having become the world’s biggest drug company by swallowing up Warner Lambert, Pharmacia, Wyeth and others....
...The result of a larger company making more modest bets is that revenue growth will resemble a consumer goods company more than one that lives and dies by billion-dollar molecules....
...Later, it expanded its presence by acquiring other companies, such as Warner Lambert, Pharmacia and, most recently, Wyeth – a champion of biological products such as the Prevnar vaccine – that had also had...
...AstraZeneca was created in a £52bn ($102bn) deal in 1999; GlaxoSmithKline from a £120bn deal in 2001 while Pfizer launched a $53bn takeover of Pharmacia in 2003....
...Acquired when Pfizer bought Pharmacia in a takeover completed in 2000, Bextra, a painkiller in the same Cox-2 class as Merck’s Vioxx, was one of two drugs drawn to the attention of regulators and lawyers...
International Edition